Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Netflix, Inc. (“Netflix” or “the Company”) (NASDAQ: NFLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

After recent volatile sessions, Oracle's (NYSE: ORCL) share price is surging as investors react to Wall Street's bullish outlook on the company's key partnership in artificial intelligence.

Record Thanksgiving travel and rebounding bookings are expected to lift airline ETFs like JETS as industry momentum accelerates in the post-shutdown period.

Boeing and General Dynamics gain as major U.S. defense contractors that develop and supply advanced technologies globally.

GDOC hits a 52-week high as aging demographics, tech advances and strength from top holding LLY fuel momentum.

Robinhood accelerates its prediction-market push with a 90% MIAX Derivatives stake, aiming to build a dedicated futures and derivatives exchange by 2026.

Massive chip news from Google

Li Auto Inc. ( LI ) Q3 2025 Earnings Call November 26, 2025 7:00 AM EST Company Participants Janet Chang - Director of Investor Relations Xiang Li - Founder, Executive Chairman & CEO Tie Li - CFO & Executive Director Conference Call Participants Yingbo Xu - Citic Securities Co., Ltd., Research Division Tim Hsiao - Morgan Stanley, Research Division Ming-Hsun Lee - BofA Securities, Research Division Paul Gong - UBS Investment Bank, Research Division Tina Hou - Goldman Sachs Group, Inc., Research Division Presentation Operator Hello, ladies and gentlemen.

Criteo S.A. (CRTO) is undervalued, consistently beating earnings estimates and showing improving margins despite market skepticism. CRTO's shift to retail media and partnerships with Google and DoorDash are driving growth and diversifying its revenue streams. The stock trades at a low P/E, with strong balance sheet metrics and persistent outperformance versus sector expectations, supporting a buy rating.

CROX, ONON, RL, KTB and BOOT are five apparel and footwear names highlighted for double-digit upside despite a muted holiday backdrop.

Freeport and Southern Copper face copper price swings, but both push ahead with major projects leveraging strong cash flows.

Low-leverage stock picks like FSS are likely to gain attention as investors seek stability amid market optimism and rising hopes for a rate cut.

Alphabet nears a $4T valuation as chip deals, Gemini 3 momentum, and strong Q3 results lift ETFs like GXPC with heavy exposure.

New York, New York--(Newsfile Corp. - November 26, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), highlighting the Company's now cash-rich balance sheet, full debt repayment, settlement of a $9.5 million insurance case, and stabilization of its Contract Manufacturing Operations (CMO). The updated report also reflects management's revised outlook for EBITDA breakeven, now expected in Q3 2026.

OVV maintains a presence in Canada in the Montney Basin and in the US in the Permina Basin, taking advantage of the different royalty structure in each of the countries. The acquisition of NuVista Energy for $2.7 billion would allow the company to add 100 MBOE/D to production. OVV's EBITDA for Q3 2025 was $966 million, which, if annualized, yields an EV/EBITDA of 4.21x.

LOS ANGELES, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Hormel Foods Corporation (“Hormel” or “the Company”) (NYSE: HRL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CNQ's fresh 52-week high spotlights record production, strong cash flow and disciplined returns fueling its momentum.

JAZZ leverages Epidiolex's rising sales and its broad drug portfolio to strengthen its position in the evolving medical cannabis market.

Get a deeper insight into the potential performance of CrowdStrike (CRWD) for the quarter ended October 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.